Gujarat-based sterile-liquids pharma manufacturer of IV fluids (LVP/SVP), diluents, ophthalmic, respiratory and irrigation solutions, exported to 120+ countries
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 27 | 27 | 27 | 27 | 27 | 29 | 39 | 39 |
| Reserves | 2 | -20 | 36 | 36 | 39 | 68 | 172 | 181 |
| Borrowings | 231 | 235 | 226 | 216 | 211 | 204 | 186 | 244 |
| Other Liabilities | 127 | 150 | 104 | 96 | 75 | 81 | 92 | 93 |
| Total Liabilities | 388 | 392 | 392 | 374 | 352 | 382 | 488 | 558 |
| AssetsFixed Assets | 244 | 242 | 240 | 232 | 228 | 217 | 210 | 207 |
| CWIP | 0 | 0 | 0 | 9 | 0 | 7 | 11 | 82 |
| Investments | 0 | 2 | 3 | 0 | 4 | 8 | 8 | 7 |
| Other Assets | 144 | 149 | 149 | 133 | 120 | 150 | 259 | 262 |
| Total Assets | 388 | 392 | 392 | 374 | 352 | 382 | 488 | 558 |
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 38 | 31 | 62 | 43 | 58 | 47 | 48 |
| Cash from Investing | -9 | -13 | -6 | -7 | -10 | -24 | -94 |
| Cash from Financing | -37 | -18 | -50 | -42 | -46 | -23 | 126 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — |
| Free Cash Flow | 27 | 19 | 52 | 36 | 46 | 26 | -32 |
| FCF Margin | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
AMANTA · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.